معرفی
Dr. Arjan Diepstra is an academic hematopathologist and Associate Professor at the University of Groningen's Faculty of Medical Sciences, Department of Pathology. He holds leadership roles including Program Leader at the Cancer Research Center Groningen (CRCG), Chair of the UMCG Pathology Department's ethical committee, and Chair of the national HOVON pathology facility (HOP). His research focuses on malignant lymphomas, particularly Hodgkin lymphoma, emphasizing tumor-microenvironment interactions and molecular diagnostics.
Education: PhD in Pathology (2007) with a thesis on HLA and EBV in Hodgkin lymphoma, published in high-impact journals like the Lancet and Journal of Clinical Oncology. He has secured grants from the Dutch Cancer Society and industry partners like Takeda and EUSA Pharma.
Research Interests: Immunology, tumor cell biology, association studies, and molecular diagnostics in hematopathology. Key projects include genome-wide association studies via the Interlymph consortium and translational research in EORTC lymphoma trials. His work explores biomarkers like TARC for early relapse detection and therapeutic strategies in lymphoma.
Awards: Not explicitly listed, but his work has received grants and collaborative support from major institutions and pharmaceutical companies.
Advising & Grants: Leads translational research workstreams, chairs international pathology groups, and collaborates with global teams. Oversees clinical trials and advisory boards for therapies targeting lymphomas like Castleman's disease.
Labs/Teams: Active in the SALL program (Stem Cells, Aging, Leukemia, Lymphoma) at CRCG, and contributes to the WHO tumor classifications through editorial roles.
